We are live on ! Find out more
KIN

Kindred Biosciences, Inc.
KIN

Delisted

KIN was delisted on the 27th of August, 2021.

Back to rankings

20 hedge funds and large institutions have $91.5M invested in Kindred Biosciences, Inc. in 2013 Q4 according to their latest regulatory filings, with 20 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
20
Holders Change
+20
Holders Change %
–
% of All Funds
0.58%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
20
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
BG
Baupost Group
Massachusetts
+$34.6M
2
Adage Capital Partners
Adage Capital Partners
Massachusetts
+$15.7M
3
Fidelity Investments
Fidelity Investments
Massachusetts
+$13.1M
4
Jennison Associates
Jennison Associates
New York
+$10.7M
5
KCM
Kingdon Capital Management
New York
+$7.15M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
BG
1
Baupost Group
Massachusetts
$32.4M +$34.6M +2,900,000 New
Adage Capital Partners
2
Adage Capital Partners
Massachusetts
$14.8M +$15.7M +1,321,372 New
Fidelity Investments
3
Fidelity Investments
Massachusetts
$12.3M +$13.1M +1,100,000 New
Jennison Associates
4
Jennison Associates
New York
$10M +$10.7M +901,774 New
KCM
5
Kingdon Capital Management
New York
$6.68M +$7.15M +600,000 New
Franklin Resources
6
Franklin Resources
California
$3.37M +$3.61M +302,800 New
DM
7
Deerfield Management
New York
$2.51M +$2.68M +225,000 New
AWMDMG
8
Austin W. Marxe & David M. Greenhouse
New York
$2.23M +$2.38M +200,000 New
PI
9
Putnam Investments
Massachusetts
$1.67M +$1.79M +150,000 New
TG
10
TCW Group
California
$1.61M +$1.72M +144,699 New
DCM
11
Driehaus Capital Management
Illinois
$1.58M +$1.69M +141,519 New
FCM
12
Farallon Capital Management
California
$918K +$983K +82,445 New
BI
13
BVF Inc
California
$577K +$617K +51,788 New
HVC
14
Healthcare Value Capital
New Jersey
$559K +$596K +50,000 New
HHC
15
Hutchin Hill Capital
New York
$131K +$140K +11,719 New
CCA
16
Catalyst Capital Advisors
New York
$111K +$119K +10,000 New
TRCT
17
Tower Research Capital (TRC)
New York
$55K +$58.6K +4,918 New
U
18
UBS
Switzerland
$14K +$15.4K +1,291 New
Morgan Stanley
19
Morgan Stanley
New York
$6K +$5.96K +500 New
Citigroup
20
Citigroup
New York
$1K +$1K +84 New

KIN Hedge Fund Activity: Q4 2013 in Review

20 of the 3,445 institutional investors tracked by Wall St. Rank reported a position in Kindred Biosciences, Inc. (KIN) for Q4 2013, worth a combined $91.5M.

Buyers outnumbered sellers: 20 funds opened new KIN positions and 0 closed out — a net gain of 20 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Baupost Group, opening a new position worth an estimated $34.6M.

  • 20 institutional investors held Kindred Biosciences, Inc. (KIN) as of Q4 2013, up from 0 in Q3 2013.
  • Funds reported $91.5M of Kindred Biosciences, Inc. stock for Q4 2013.
  • 20 funds opened new Kindred Biosciences, Inc. positions in Q4 2013 and 0 closed out, a net change of +20 holders.
  • The largest Kindred Biosciences, Inc. buyer in Q4 2013 was Baupost Group, an estimated $34.6M added.

Based on aggregated 13F filings for Q4 2013.